 |
|
|
|
 |
|
|
 |
|
 Kontakt |
 Druckansicht |
 PDF-Ansicht |
 Veranstaltung weiterempfehlen |
 RSS-Feed
|
|
|
|
Konferenz
FDA/DIA Co-sponsored Conference on The Orphan Drug Act (ODA) at 25 Years: Retrospective and Future Views19.05.2008
|
|
|
|
Veranstaltungsort:
|
Capitol Hilton, 1001 16th Street NW
20036 Washington
Vereinigte Staaten von Amerika
|
|
Themengebiete:
|
Pharma
|
|
|
Veranstalter:
|
Drug Information Association
800 Enterprise Road, Suite 200
19044 Horsham
Vereinigte Staaten von Amerika
Herr Marketing Manager
Tel.: +1.215.442.6100
Fax: +1.215.442.6199
http://www.diahome.org
|
|
|
|
Beschreibung:
|
|
|
In celebration of the 25th anniversary of the Orphan Drug Act, FDA, industry and patient advocacy groups are coming together to discuss accomplishments, perspectives, globalization, and future challenges in the development of therapeutic drugs and devices for the treatment of rare diseases.
Current updates on the processes, procedures, and resources to enable the successful movement of products for rare diseases from research to approval will be discussed. This will include information on Orphan Drug Designation applications,
Humanitarian Use Device designation applications, and Orphan Products Grant applications as well as other regulatory components. |
|
|
|
Weitere Informationen:
|
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16992&eventType=Meeting
|
|
|
|
|
|
|
|
Top